224 related articles for article (PubMed ID: 38374266)
1. VIBRANT: spectral profiling for single-cell drug responses.
Liu X; Shi L; Zhao Z; Shu J; Min W
Nat Methods; 2024 Mar; 21(3):501-511. PubMed ID: 38374266
[TBL] [Abstract][Full Text] [Related]
2. Mid-infrared metabolic imaging with vibrational probes.
Shi L; Liu X; Shi L; Stinson HT; Rowlette J; Kahl LJ; Evans CR; Zheng C; Dietrich LEP; Min W
Nat Methods; 2020 Aug; 17(8):844-851. PubMed ID: 32601425
[TBL] [Abstract][Full Text] [Related]
3. High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery.
Hughes RE; Elliott RJR; Munro AF; Makda A; O'Neill JR; Hupp T; Carragher NO
SLAS Discov; 2020 Aug; 25(7):770-782. PubMed ID: 32441181
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Activity Phenotyping of Single Cells with Multiplexed Vibrational Probes.
Zhao Z; Chen C; Xiong H; Ji J; Min W
Anal Chem; 2020 Jul; 92(14):9603-9612. PubMed ID: 32530266
[TBL] [Abstract][Full Text] [Related]
5. Active Learning Strategies for Phenotypic Profiling of High-Content Screens.
Smith K; Horvath P
J Biomol Screen; 2014 Jun; 19(5):685-95. PubMed ID: 24643256
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 4 different machine learning algorithms to predict lactoferrin content in bovine milk from mid-infrared spectra.
Soyeurt H; Grelet C; McParland S; Calmels M; Coffey M; Tedde A; Delhez P; Dehareng F; Gengler N
J Dairy Sci; 2020 Dec; 103(12):11585-11596. PubMed ID: 33222859
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.
McFarland JM; Paolella BR; Warren A; Geiger-Schuller K; Shibue T; Rothberg M; Kuksenko O; Colgan WN; Jones A; Chambers E; Dionne D; Bender S; Wolpin BM; Ghandi M; Tirosh I; Rozenblatt-Rosen O; Roth JA; Golub TR; Regev A; Aguirre AJ; Vazquez F; Tsherniak A
Nat Commun; 2020 Aug; 11(1):4296. PubMed ID: 32855387
[TBL] [Abstract][Full Text] [Related]
8. Developing a FHIR-based EHR phenotyping framework: A case study for identification of patients with obesity and multiple comorbidities from discharge summaries.
Hong N; Wen A; Stone DJ; Tsuji S; Kingsbury PR; Rasmussen LV; Pacheco JA; Adekkanattu P; Wang F; Luo Y; Pathak J; Liu H; Jiang G
J Biomed Inform; 2019 Nov; 99():103310. PubMed ID: 31622801
[TBL] [Abstract][Full Text] [Related]
9. Predicting cellular responses to complex perturbations in high-throughput screens.
Lotfollahi M; Klimovskaia Susmelj A; De Donno C; Hetzel L; Ji Y; Ibarra IL; Srivatsan SR; Naghipourfar M; Daza RM; Martin B; Shendure J; McFaline-Figueroa JL; Boyeau P; Wolf FA; Yakubova N; Günnemann S; Trapnell C; Lopez-Paz D; Theis FJ
Mol Syst Biol; 2023 Jun; 19(6):e11517. PubMed ID: 37154091
[TBL] [Abstract][Full Text] [Related]
10. Evaluating batch correction methods for image-based cell profiling.
Arevalo J; Su E; van Dijk R; Carpenter AE; Singh S
bioRxiv; 2024 Feb; ():. PubMed ID: 37745478
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Machine Learning Classifiers to Predict Compound Mechanism of Action When Transferred across Distinct Cell Lines.
Warchal SJ; Dawson JC; Carragher NO
SLAS Discov; 2019 Mar; 24(3):224-233. PubMed ID: 30694704
[TBL] [Abstract][Full Text] [Related]
12. Predicting cell health phenotypes using image-based morphology profiling.
Way GP; Kost-Alimova M; Shibue T; Harrington WF; Gill S; Piccioni F; Becker T; Shafqat-Abbasi H; Hahn WC; Carpenter AE; Vazquez F; Singh S
Mol Biol Cell; 2021 Apr; 32(9):995-1005. PubMed ID: 33534641
[TBL] [Abstract][Full Text] [Related]
13. High-content phenotypic profiling of drug response signatures across distinct cancer cells.
Caie PD; Walls RE; Ingleston-Orme A; Daya S; Houslay T; Eagle R; Roberts ME; Carragher NO
Mol Cancer Ther; 2010 Jun; 9(6):1913-26. PubMed ID: 20530715
[TBL] [Abstract][Full Text] [Related]
14. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
[TBL] [Abstract][Full Text] [Related]
15. A Decade in a Systematic Review: The Evolution and Impact of Cell Painting.
Seal S; Trapotsi MA; Spjuth O; Singh S; Carreras-Puigvert J; Greene N; Bender A; Carpenter AE
ArXiv; 2024 May; ():. PubMed ID: 38745696
[TBL] [Abstract][Full Text] [Related]
16. A Decade in a Systematic Review: The Evolution and Impact of Cell Painting.
Seal S; Trapotsi MA; Spjuth O; Singh S; Carreras-Puigvert J; Greene N; Bender A; Carpenter AE
bioRxiv; 2024 May; ():. PubMed ID: 38766203
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Profiling of Reference Chemicals across Biologically Diverse Cell Types Using the Cell Painting Assay.
Willis C; Nyffeler J; Harrill J
SLAS Discov; 2020 Aug; 25(7):755-769. PubMed ID: 32546035
[TBL] [Abstract][Full Text] [Related]
18. Label-free detection of cellular drug responses by high-throughput bright-field imaging and machine learning.
Kobayashi H; Lei C; Wu Y; Mao A; Jiang Y; Guo B; Ozeki Y; Goda K
Sci Rep; 2017 Sep; 7(1):12454. PubMed ID: 28963483
[TBL] [Abstract][Full Text] [Related]
19. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
